01.03.2000 | ORIGINAL ARTICLE
Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction
Erschienen in: Supportive Care in Cancer | Ausgabe 3/2000
Einloggen, um Zugang zu erhalten